Bullish Moving Averages
14
Bearish Moving Averages
2
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
159.20Today’s High
169.2052W low
46.6052W High
179.40Open Price
169.20Prev. Close
145.3000Volume
264506.00Value
42439987.70Fundamentals
Market Cap
525.40
Price to Earnings
9.40
Price to Book Value
18.80
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
575.65
Net Profit TTM
55.96
Cash From Operating Activity
3.98
Return on Equity %
200.26
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
77
Week
75.8
Month
69.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
162.96
PIVOT
First Resistance
166.72
Second Resistance
172.99
Third Resistance
176.75
First Support
156.69
Second Support
152.93
Third Support
146.66
Relative Strength Index
54.79
Money Flow Index
71.4
MACD
2.67
MACD Signal
2.54
Average True Range
7.37
Average Directional Index
19.31
Rate of Change (21)
12.12
Rate of Change (125)
27.34
Commodity Channel Index
73.6
Williams %R
-55.4
BETA
1 Month
0.89
3 Month
0.65
1 Year
0.58
3 Year
0.19
PRICE CHANGE ANALYSIS
↑ 3.37%
1 Week
Low
High
154.99
169.23
↑ 12.12%
1 Month
Low
High
142.2
169.23
↓ -4.24%
3 Months
Low
High
131.2
175
↑ 25.35%
6 Months
Low
High
123
179.35
↑ 191.46%
1 Year
Low
High
46.6
179.35
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 140.33 | 146.19 | 145.22 | 146.90 | 130.91 | 126.04 | 124.74 | 118.87 | 135.04 | 125.09 | 124.40 | |
| Operating Expenses Qtr | 121.24 | 124.35 | 127.12 | 132.94 | 118.81 | 119.32 | 118.36 | 119.98 | 121.58 | 115.99 | 116.98 | |
| Operating Profit Qtr | 18.16 | 21.15 | 17.34 | 13.35 | 14.16 | 6.46 | 5.60 | -3.04 | 12.81 | 8.84 | 7.11 | |
| EBIDT Qtr Cr | 19.09 | 21.84 | 18.10 | 13.96 | 11.51 | 6.72 | 6.38 | -1.11 | 89.82 | 9.10 | 7.42 | |
| Depreciation Qtr | 3.28 | 3.32 | 3.24 | 3.18 | 3.07 | 3.13 | 3.15 | 3.03 | 3.00 | 3.03 | 2.78 | |
| Net Profit Qtr | 8.08 | 10.27 | 7.36 | 4.69 | 1.02 | -3.28 | -0.89 | -7.24 | 82.54 | 0.37 | -0.58 | |
| Basic EPS Qtr | 2.47 | 3.14 | 2.25 | 1.43 | 0.49 | -1.00 | -0.27 | -2.22 | 1.92 | 0.12 | -0.17 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 578.64 | 500.56 | 512.69 | 394.92 | 368.59 | |
| Operating Expenses Annual Cr | 505.65 | 476.48 | 475.87 | 374.50 | 344.01 | |
| Operating Profit Annual | 70.00 | 23.17 | 35.31 | 18.02 | 23.45 | |
| Operating Profit Margin Annual % | 12.10 | 4.63 | 6.89 | 4.56 | 6.36 | |
| Total Expenses Annual Cr | 547.86 | 510.25 | 507.93 | 407.33 | 386.56 | |
| EBIDT Annual Cr | 72.99 | 24.09 | 36.82 | 20.42 | 24.59 | |
| EBIDT Annual margin % | 12.61 | 4.81 | 7.18 | 5.17 | 6.67 | |
| Depreciation | 13.03 | 12.38 | 11.45 | 9.75 | 9.68 | |
| PAT Before ExtraOrdinary Items Annual Cr | 30.40 | -10.40 | 81.47 | -12.61 | 64.46 | |
| Net Profit Annual | 30.40 | -10.40 | 81.47 | -12.61 | 64.46 | |
| Basic EPS Annual | 9.29 | -3.18 | 25.29 | -5.04 | 26.90 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 27.94 | -7.26 | 2.19 | -130.66 | -117.83 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 101.45 | 16.31 | 16.20 | 90.07 | 111.10 | |
| Total Current Liabilities Annual Cr | 214.11 | 293.19 | 332.62 | 328.19 | 283.89 | |
| Total Capital Plus Liabilities Annual Cr | 343.49 | 302.25 | 351.00 | 287.60 | 277.16 | |
| Fixed Assets Annual | 169.83 | 168.71 | 169.46 | 178.40 | 177.79 | |
| Total Non Current Assets Annual | 184.21 | 179.74 | 179.34 | 187.91 | 185.06 | |
| Total Current Assets Annual | 159.29 | 122.50 | 171.66 | 99.69 | 92.11 | |
| Total Assets Annual | 343.49 | 302.25 | 351.00 | 287.60 | 277.16 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 945.26 | 908.54 | 862.78 | 1009.04 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 4.02 | 19.80 | 40.52 | 16.68 | 44.13 | |
| Cash from Investing Activity Annual | -16.63 | -8.84 | 0.59 | 8.04 | 63.66 | |
| Cash from Financing Annual Activity | 14.55 | -31.99 | -28.58 | -17.39 | -107.87 | |
| Net Cash Flow Annual | - | -21.03 | 12.53 | 7.34 | -0.09 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 8.53 | -2.22 | 0.67 | -52.23 | -47.14 | |
| ROE Annual % | 108.79 | 0.00 | 3724.18 | 0.00 | -54.70 | |
| ROCE Annual % | 46.34 | 129.25 | 138.00 | -26.28 | -221.47 | |
| Total Debt to Total Equity Annual | 3.94 | -8.84 | 30.64 | -0.68 | -1.06 | |
| EBDIT Annual Margin % | 12.67 | 4.82 | 7.20 | 5.20 | 6.69 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 140.33 | 146.19 | 145.22 | 146.90 | 130.91 | 126.04 | 124.74 | 118.87 | 135.04 | 125.09 | 124.40 | |
| Operating Expenses Qtr | 121.24 | 124.35 | 127.12 | 132.94 | 118.81 | 119.32 | 118.36 | 119.98 | 121.58 | 115.99 | 116.98 | |
| Operating Profit Qtr | 18.16 | 21.15 | 17.34 | 13.35 | 14.16 | 6.46 | 5.60 | -3.04 | 12.81 | 8.84 | 7.11 | |
| EBIDT Qtr Cr | 44.65 | 21.84 | 18.10 | 13.96 | 11.51 | 6.72 | 6.38 | -1.11 | 89.82 | 9.10 | 7.42 | |
| Depreciation Qtr | 3.28 | 3.32 | 3.24 | 3.18 | 3.07 | 3.13 | 3.15 | 3.03 | 3.00 | 3.03 | 2.78 | |
| Net Profit Qtr | 33.63 | 10.27 | 7.36 | 4.69 | 1.02 | -3.28 | -0.89 | -7.24 | 82.54 | 0.37 | -0.58 | |
| Basic EPS Qtr | 10.28 | 3.13 | 2.25 | 1.43 | 0.49 | -1.00 | -0.27 | -2.22 | 1.92 | 0.12 | -0.17 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 578.64 | 500.56 | 512.69 | 394.92 | 368.59 | |
| Operating Expenses Annual Cr | 505.65 | 476.48 | 475.87 | 374.50 | 344.01 | |
| Operating Profit Annual | 70.00 | 23.17 | 35.31 | 18.02 | 23.45 | |
| Operating Profit Margin Annual % | 12.10 | 4.63 | 6.89 | 4.56 | 6.36 | |
| Total Expenses Annual Cr | 547.86 | 510.25 | 507.93 | 407.33 | 386.56 | |
| EBIDT Annual Cr | 72.99 | 24.09 | 36.82 | 20.42 | 24.58 | |
| EBIDT Annual margin % | 12.61 | 4.81 | 7.18 | 5.17 | 6.67 | |
| Depreciation | 13.03 | 12.38 | 11.45 | 9.75 | 9.68 | |
| PAT Before ExtraOrdinary Items Annual Cr | 55.96 | -10.40 | 81.47 | -12.61 | 64.46 | |
| Net Profit Annual | 55.96 | -10.40 | 81.47 | -12.61 | 64.46 | |
| Basic EPS Annual | 15.89 | -3.18 | 25.29 | -5.04 | 26.90 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 27.94 | -32.82 | -23.42 | -156.24 | -143.45 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 101.45 | 16.31 | 16.20 | 90.07 | 111.10 | |
| Total Current Liabilities Annual Cr | 214.11 | 320.38 | 359.77 | 355.35 | 311.04 | |
| Total Capital Plus Liabilities Annual Cr | 343.49 | 303.87 | 352.55 | 289.18 | 278.69 | |
| Fixed Assets Annual | 152.29 | 168.71 | 169.46 | 178.40 | 177.79 | |
| Total Non Current Assets Annual | 184.21 | 179.74 | 179.34 | 187.91 | 185.06 | |
| Total Current Assets Annual | 159.29 | 124.13 | 173.20 | 101.27 | 93.64 | |
| Total Assets Annual | 343.49 | 303.87 | 352.55 | 289.18 | 278.69 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 1033.26 | 908.54 | 889.88 | 1012.55 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 3.98 | 19.80 | 40.52 | 16.68 | 44.13 | |
| Cash from Investing Activity Annual | -16.63 | -8.84 | 0.59 | 8.04 | 63.66 | |
| Cash from Financing Annual Activity | 14.55 | -31.99 | -28.58 | -17.39 | -107.87 | |
| Net Cash Flow Annual | - | -21.03 | 12.53 | 7.34 | -0.08 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 8.53 | -10.03 | -7.17 | -62.46 | -57.39 | |
| ROE Annual % | 200.26 | 0.00 | -347.88 | 0.00 | -44.93 | |
| ROCE Annual % | 46.34 | -70.89 | -351.22 | -16.12 | -46.06 | |
| Total Debt to Total Equity Annual | 3.94 | -1.95 | -2.86 | -0.57 | -0.87 | |
| EBDIT Annual Margin % | 12.67 | 4.82 | 7.20 | 5.20 | 6.69 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| EXPERT CHEMICALS (INDIA) PVT LTD | 30.56 | 74803076 | 92.52 | 0.07 |
| KINGSBURY INVESTMENTS INC. | 9.23 | 74803078 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| VIJAY K CHORARIA | 2.29 | 74803095 |
| SURESH BHATIA | 2.2 | 74803096 |
| VARALAKSHMI VELDI . | 1.21 | 74803097 |
| ELIZABETH MATHEW . | 1.13 | 74803098 |
| MILAN MANHARKANT GANATRA | 1.08 | 74803099 |
| HUF | 2.63 | 74803085 |
| LLP | 1.53 | 74803086 |
| EAST EIGHT SIX ADVISORS LLP | 1.41 | 74803087 |
| Clearing Members | 0.75 | 74803088 |
| AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED | 2.35 | 74803090 |
| MAGNUM EQUIFIN PRIVATE LIMITED | 1.53 | 74803091 |
| YANNI GLOBAL (OPC) PRIVATE LIMITED | 1.05 | 74803092 |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS | 1.03 | 74803104 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 29, 2010 | 1 | FINAL | - | Equity Share |
| Mar 12, 2009 | 0.5 | FINAL | - | Equity Share |
| Sep 13, 2007 | 2 | FINAL | - | Equity Share |
| Sep 07, 2006 | 1.5 | FINAL | - | Equity Share |
| Feb 20, 2006 | 0.5 | INTERIM | Feb 21, 2006 | Equity Share |
| Jul 28, 2005 | 1 | FINAL | - | Equity Share |
| Sep 02, 2002 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 16, 2024 | Audited Results | - |
| Jan 24, 2024 | Quarterly Results | - |
| Oct 20, 2023 | Quarterly Results & Preferential issue | Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company. |
| Aug 11, 2023 | Quarterly Results | - |
| Jun 09, 2023 | Audited Results | (Revised) |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 28, 2022 | Quarterly Results | (Revised) |
| Aug 10, 2022 | Quarterly Results | - |
| Jun 22, 2022 | Audited Results | - |
| Feb 17, 2022 | Preferential issue of shares | - |
| Feb 08, 2022 | Quarterly Results | - |
| Nov 25, 2021 | Quarterly Results | (Revised) |
| Oct 20, 2021 | Quarterly Results | - |
| Sep 20, 2021 | Quarterly Results | (Revised) |
| Aug 12, 2021 | Audited Results | - |
| Jun 28, 2021 | Audited & Quarterly Results | - |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results | - |
| Sep 11, 2020 | Quarterly Results | - |
| Jul 22, 2020 | Audited & Quarterly Results | (Revised) |
| Jun 25, 2020 | Audited Results | - |
| Feb 14, 2020 | Quarterly Results | - |
| Nov 13, 2019 | Quarterly Results | - |
| Oct 22, 2019 | Preferential Issue of shares | inter alia, 1. The issue and allotment upto 13,95,500 Equity Shares to M/s. Edelweiss Asset Reconstruction Company Ltd. ('EARC') as a trustee of EARC Trust SC 145 on preferential basis. |
| Sep 20, 2019 | Others | inter alia, to consider and approve debt settlement plan, opportunity to raise fund for settlement of debt with Lenders and review of operations. |
| Aug 14, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results | - |
| Feb 14, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 10, 2018 | Quarterly Results | - |
| Aug 09, 2018 | Audited Results | - |
| Feb 08, 2018 | Quarterly Results | - |
| Dec 07, 2017 | Quarterly Results | - |
| Sep 11, 2017 | Quarterly Results | - |
| May 30, 2017 | Audited Results | - |
| Feb 14, 2017 | Quarterly Results | - |
| Nov 29, 2016 | Quarterly Results | (Revised from 08/11/2016) |
| Aug 12, 2016 | Quarterly Results | - |
| May 18, 2016 | Audited Results | - |
| Feb 11, 2016 | Quarterly Results | - |
| Nov 05, 2015 | Quarterly Results | 1. Grant of Employee Stock Option Plan (ESOP) to the extent of 3,00,000 equity shares to the employee/s of the Company. 2. Assignment of Financial Assistance granted to Wanbury Limited by State Bank. |
| Sep 28, 2015 | Others | 1. Resignation of Mr. A. L. Bongirwar as Independent Director of the Company vides his dated September 28, 2015. 2. Resignation of Dr. P. L. Tiwari as Independent Director of the Company. |
| Aug 13, 2015 | Quarterly Results | Appointment of Ms. Anita Belani as an Additional Independent Woman Director. |
| May 21, 2015 | Audited Results | Mr. Jitendra J. Gandhi as Compliance Officer of the Company who has joined as Company Secretary of the Company w.e.f. April 20, 2015. |
| Feb 11, 2015 | Quarterly Results | - |
| Nov 26, 2014 | Quarterly Results | - |
| Aug 07, 2014 | Quarterly Results | - |
| May 12, 2014 | Quarterly Results | - |
| Feb 11, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Aug 12, 2013 | Quarterly Results | - |
| May 30, 2013 | Audited Results | - |
| Feb 07, 2013 | Quarterly Results | - |
| Nov 05, 2012 | Quarterly Results | - |
| Aug 06, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results | - |
| Feb 10, 2012 | Quarterly Results | - |
| Nov 07, 2011 | Quarterly Results | - |
| Sep 27, 2011 | Others | - |
| May 30, 2011 | Audited Results | - |
| Feb 02, 2011 | Quarterly Results | - |
| Oct 29, 2010 | Quarterly Results | - |
| Aug 12, 2010 | Quarterly Results | - |
| May 28, 2010 | Audited Results | - |
| Jan 22, 2010 | Quarterly Results | - |
| Dec 23, 2009 | Employees Stock Option Plan & Others | To consider the Employee Stock Option Scheme for the Employees of the Company & to draft the rehabilitation scheme for the Merger of Pharmaceuticals Products of India Ltd. with the Company. |
| Oct 28, 2009 | Quarterly Results | - |
| Sep 29, 2009 | To consider the Cost Audit Report | inter alia, to consider the Cost Audit Report of the Company for the financial year 2008-2009 i.e., for the 6 months period from October 01, 2008 to March 31, 2009. |
| Jul 27, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results | 6 months period from 1st October 2008 to 31st March 2009. |
| Jun 03, 2009 | Others | To avail the Term Loan of Rs 19.5 Crore, working capital facility of Rs 11 Crore & Availing Fund Based Working Capital Facility of Rs 9.50 Cr. & Non fund Based Working Capital Facility of Rs 7.90 Cr. |
| Jan 30, 2009 | Quarterly Results | - |
| Dec 31, 2008 | Audited Results, Dividend & Others | inter alia, to consider the date and notice of Annual General Meeting. (For 18 months) |
| Nov 28, 2008 | To appoint Cost Auditor | inter alia, to consider appointment of Cost Auditor of the company for the financial year 2008-2009. |
| Jul 29, 2008 | Quarterly Results | - |
| Jun 27, 2008 | Quarterly Results | - |
| Apr 28, 2008 | Appointment of Cost Auditor | - |
| Jan 30, 2008 | Quarterly Results | - |
| Oct 31, 2007 | Quarterly Results | - |
| Sep 27, 2007 | Others | inter alia, to consider the following: 1. The Cost Audit Report for the financial year 2006-2007. 2. The sitting fees to be paid to the non-executive directors for attending the Board Meeting. |
| Jul 30, 2007 | Quarterly Results | - |
| Jun 29, 2007 | Audited Results & Dividend | - |
| May 28, 2007 | Appointment of Cost Auditor | To consider and approve the appointment of Cost Auditor for the Financial Year 2007-2008. |
| Mar 14, 2007 | To consider & allot FCCB's | To consider and approve allotment of Foreign Currency Convertible Bonds (FCCBs). |
| Jan 31, 2007 | Quarterly Results | - |
| Jan 04, 2007 | Enhancement of Working Capital Limits | 1. Enhancement of Working Capital Limits sanctioned by Consortium of Bank of India, Exim Bank and Dhanlakshmi Bank. 2. Foreign Currency Convertible Bonds (FCCB) / Qualified Institutional Placement. |
| Oct 16, 2006 | Quarterly Results | - |
| Sep 07, 2006 | Others | To convene Extra Ordinary General Meeting to get the approval of the Shareholders of the Company for the scheme of merger of Doctors Organic Chemicals Ltd with the Company. |
| Jul 31, 2006 | Quarterly Results | - |
| Jun 26, 2006 | Accounts, Final Dividend & Merger | - |
| Apr 28, 2006 | Others | Appointment of Cost Auditor - Mr Hemant V Shah for the financial year 2006-2007 subject to the approval of Central Government. |
| Jan 30, 2006 | Quarterly Results & Interim Dividend | 1) To consider and approve working capital facilities and short term Foreign Exchange facility from DBS Bank of Rs. 7.50 crores. 2) To consider and approve credit limit from State Bank of India. |
| Oct 28, 2005 | Half Yearly Results | - |
| Oct 03, 2005 | Allotment of equity shares | To consider & approve the allotment of equity shares for issue of GDRs. |
| Sep 12, 2005 | Amalgamation | Merger of The Pharmaceuticals Products of India Ltd. with the Company |
| Jul 30, 2005 | Quarterly Results | - |
| Jun 24, 2005 | Increase in Authorised Capital | - |
| Apr 14, 2005 | To present business plan | Proposed acquisition of PPIL & Proposed Arrangement between Pharmaceutical Products India Ltd, Secured Creditors of Pharmaceutical Products India Ltd and the Company. |
| Jan 28, 2005 | Quarterly Results | - |
| Oct 27, 2004 | Quarterly Results | - |
| Oct 15, 2004 | Others | Allotment & Issue of Equity Share to the Shareholders of the transferor Co. pursuant to the High Court approval for Scheme of merger & Reduction of Capital. |
| Sep 27, 2004 | Accounts & Dividend | - |
| Sep 08, 2004 | Amalgamation & Reduction of Capital | Face value of equity shares from Rs.10/-each to Rs.5/-each per share and immediately thereafter cosolidation of two equity shares as so reduced into one equity share of Rs.10/- each fully paid up. |
| Aug 12, 2004 | Others | To change of name of the company and approval of the notice of the EGM. |
| Jul 28, 2004 | Quarterly Results | - |
| Apr 27, 2004 | Quarterly Results | - |
| Jan 30, 2004 | Others | Discuss the proposal of merger of the company and M/s. Wander Pvt.Ltd. and appoint valuer and related issues. |
| Jan 23, 2004 | Quarterly Results | - |
| Oct 30, 2003 | Quarterly Results | - |
| Sep 22, 2003 | Others | To approve issuance of Equity shares as per Special Resolution. |
| Aug 06, 2003 | Preferential Issue of shares | - |
| Jul 28, 2003 | Quarterly Results | - |
| Apr 25, 2003 | Quarterly Results | - |
| Jan 28, 2003 | Quarterly Results | - |
| Dec 20, 2002 | Others | Proposal for acquisition of certain Brands and fix up schedule for Extra Ordinary General Meetings of the members to be held for Preferential allotment of Equity Shares in terms of SEBI Guidelines. |
| Oct 23, 2002 | Quarterly Results | - |
| Jul 18, 2002 | Quarterly Results | - |
| Apr 17, 2002 | Quarterly Results, Dividend & Accounts | - |
| Jan 15, 2002 | Quarterly Results | - |
| Oct 30, 2001 | Quarterly Results | - |
| Jul 23, 2001 | Accounts, Dividend & Quarterly Results | - |
| Apr 24, 2001 | Quarterly Results | - |
| Jan 23, 2001 | Quarterly Results | - |
| Oct 25, 2000 | Quarterly Results | - |
| Jul 03, 2000 | Accounts & Dividend | - |
| Apr 28, 2000 | Quarterly Results | - |
| Apr 27, 2000 | Quarterly Results | - |
| Oct 29, 1999 | Quarterly Results | - |
| Jul 29, 1999 | Quarterly Results | - |
| Jan 27, 1999 | Quarterly Results | - |
| Oct 28, 1998 | Quarterly Results | - |
| Jul 29, 1998 | Quarterly Results | - |
| May 26, 1998 | Half Yearly Results | - |
| Nov 26, 1997 | Half Yearly Results | - |
| Aug 08, 1997 | Accounts | - |
| May 31, 1997 | Half Yearly Results. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
03 Jul 2024
WANBURY LTD. - 524212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
27 Jun 2024
WANBURY LTD. - 524212 - Closure of Trading Window
Closure of Trading Window for dealing in securities of the Company in terms of SEBI (PIT) Regulations, 2015
27 Jun 2024
WANBURY LTD. - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release: Disbursement of Rs. 60 crore term loan facility by Tata Capital Limited
26 Jun 2024
WANBURY LTD. - 524212 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you, pursuant to Regulation 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, this is to inform you that the Company is meeting analysts / investors is to be held on 28th June, 2024.
25 Jun 2024
WANBURY LTD. - 524212 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation towards issue of duplicate share certificate
18 Jun 2024
WANBURY LTD. - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Successful US FDA Inspection at Patalganga Site with Zero Observations
18 Jun 2024
WANBURY LTD. - 524212 - Successful US FDA Inspection At Patalganga Site With Zero Observations
Successful US FDA Inspection at Patalganga Site with Zero Observations
30 May 2024
WANBURY LTD. - 524212 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the F.Y. ended 31st March, 2024
17 May 2024
WANBURY LTD. - 524212 - Disclosure Under Regulation 7(3) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 As Amended (SEBI PIT Regulations)
Pursuant to regulation 7(3) of SEBI PIT Regulations, please find enclosed herewith dated 17th May 2024 in Form D as received from SBICAP trustee Company Limited.
17 May 2024
WANBURY LTD. - 524212 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd
